Background
Pulmonary arterial hypertension
Methods
Objectives
Development of a conceptual model
Qualitative patient interviews
Psychometric validation study
Measures
LPH Questionnaire
6MWT
The Borg CR10 scale
World Health Organisation (WHO) functional class
EuroQol-5D (EQ-5D)
Analysis
Analysis performed | Description |
---|---|
Quality of completion of the LPH | A description of the level of completion of the LPH was performed on all questionnaires received during the study. |
Description of the items of the LPH | The frequency and percentage of responses for each response choice, including missing data was described for each of the LPH items. |
Description of the baseline LPH population | Patient parameters including age, gender, height and weight, blood pressure level, WHO functional class, 6MWD and Borg CR10 scale score were described at baseline. |
Confirmation of the structure of the LPH | Multitrait analysis was used to confirm the item groupings in the Physical and Emotional LPH dimensions. This analysis also served to test the item convergent validity criterion of the Total score. Correlation coefficients between the Total score and Physical and Emotional dimension scores were also calculated. Confirmatory Factor Analysis (CFA) was used to confirm the structure of the LPH. |
Description of the LPH Scores | The distribution of the LPH scores and changes in scores between baseline and week 12 was described. The frequency and percentage of patients scoring at floor and ceiling for each LPH score was described. |
Internal consistency reliability | Internal consistency refers to the extent to which individual items are consistent with each other and reflect a single underlying construct. Cronbach’s alpha statistic is commonly used to assess internal consistency reliability. A Cronbach’s alpha coefficient of >0.70 is typically used as the criterion for acceptable internal consistency reliability [41, 42]. Cronbach’s alpha was calculated at baseline (V0) on the baseline LPH population and at V6 on the V6 LPH population for the total score and for the Physical and Emotional dimension scores of the LPH. |
Clinical Validity | Clinical validity evaluates the extent to which the questionnaire is able to detect variability among patients with different clinical severity levels. The LPH Total and Physical and Emotional dimension scores were described according to WHO functional class, 6MWD and Borg CR 10 Scale. |
Responsiveness | Responsiveness refers to the ability of a measure to detect clinically important changes [43]. The responsiveness of the LPH Total score and Physical and Emotional dimension scores was assessed after 12 weeks. Change in scores from baseline was assessed according to change in WHO functional class (improved: change to a lower WHO functional class; stable: no change in WHO functional class; worsened: change to a higher WHO functional class), 6MWD (improved: change in 6MWD > 50; stable: -50 ≤ change in 6MWD ≤ 50; worsened: change in 6MWD <-50) and Borg CR10 Scale (improved: change in Borg CR 10 Scale < 1; stable: -1 ≤ change in Borg CR 10 Scale ≤ 1; worsened: change in Borg CR 10 Scale > 1) [44]. |
Minimal Important Difference (MID) | Analyses to provide an estimation of MID for the LPH scores were performed [45]. Two types of methods exist to estimate the MID: distribution-based and anchor-based methods. The main distribution-based method was based on Cohen’s effect-size; the MID was calculated as 0.2 × STDBL
[46] and as 0.5 × STDBL, with STDBL the standard deviation of the score at V0. The SEM was also used as a distributional estimate of MID; it was calculated as, where STDBL is the standard deviation at V0 and r the reliability coefficient. Within the anchor-based methods change in scores between V0 and V6 on the WHO functional class (patients were considered 'minimally improved’ of they changed to a lower functional class), 6MWD (patients were considered 'minimally improved’ if the 6MWD increased by 50m between V0 and V6) and Borg CR10 scale (patients were considered as 'minimally improved’ if their scale decreased by 1 between V0 and V6) were used as anchors [44]. |
Results
Qualitative patient interviews
Demographic or clinical characteristic | US | Germany | France | Total |
---|---|---|---|---|
(n=12) | (n=14) | (n=12) | (n=38) | |
Demographic Characteristics
| ||||
Age (years)
| ||||
Mean | 57.7 | 61.9 | 52.6 | 57.6 |
Median | 58.5 | 62.5 | 55.5 | 58.5 |
Min, Max | 41, 79 | 31, 85 | 25, 80 | 25, 85 |
Gender n (%)
| ||||
Male | 3 (25) | 3 (21) | 2 (16.7) | 8 (21.1) |
Female | 9 (75) | 11 (78.6) | 10 (83.3) | 30 (78.9) |
Highest education level n (%)
| ||||
Primary school | 0 | 0 | 3 (25) | 3 (7.9) |
Before high school | 0 | 0 | 1 (8.3) | 1 (2.6) |
Some high school | 0 | 0 | 0 (0) | 0 (0) |
High school diploma or GED | 4 (33.3) | 2 (14.3) | 4 (33.3) | 10 (26.3) |
Some years of college | 1 (8.3) | 0 | 1 (8.3) | 2 (5.3) |
Certificate program | 0 | 4 (28.6) | 0 (0) | 4 (10.5) |
College or university degree (2 or 4 year) | 5 (41.6) | 0 | 2 (16.7) | 7 (18.4) |
Graduate or professional degree | 2 (16.7) | 7 (50) | 0 (0) | 9 (23.7) |
No education* | 0 | 0 | 1 (8.3) | 1 (2.6) |
Skill training | 0 | 1 (7) | 0 | 1 (2.6) |
Clinical Characteristics
| ||||
Time since patient first diagnosed with PAH? (years)
| ||||
Mean | 2.2 | 2.7 | 9.4 | 4.3 |
Median | 1.5 | 2 | 6.5 | 2.5 |
Min, max | 0, 6 | 0, 8 | 2, 29 | 0, 29 |
Duration of current PAH treatment? (months)
| ||||
Mean | 15.8 | 37.9 | 42.3 | 31.7 |
Median | 12 | 23 | 36 | 21.5 |
Min, max | 1, 48 | 2, 95 | 0, 168 | 0, 168 |
Missing data | 1 | 0 | 1 | 2 |
Symptom* | LPH item(s) assessing concept |
---|---|
Shortness of breath (n=32) | 12. making you short of breath? |
Difficulty breathing (n=15) | |
Tiredness (n=34) | 13. making you tired, fatigued or lacking energy? |
Fatigue (n=16) | |
Exhaustion (n=14) | 2. making you sit or lie down to rest during the day? |
Weak (n=7) | |
Swelling in the ankles or legs (edema) (n=31) | 1. causing swelling in your ankles, legs? |
Dizziness (n=13) | No item to assess this symptom |
Fainting spells (n=7) | |
Palpitations (n=6) | No item to assess this symptom |
Headache (n=9) | No item to assess this symptom |
Problems with limbs (n=7) | No item to assess this symptom |
Impact* | LPH item(s) assessing concept |
---|---|
Activities of daily living
| |
Jobs around the home (n=36) | 4. making it difficult to work around the house or in the garden? |
Gardening (n=29) | 5. making it difficult to go anywhere away from home? |
Personal care (n=21) | |
Doing shopping (n=15) | |
Driving (n=11) | |
Caring for children (n=6) | |
Laundry (n=6) | |
Vacuuming (n=6) | |
Looking after animals (n=5) | |
Cognitive impacts
| |
Memory (n=26) | 20. making it difficult for you to concentrate or remember things? |
Concentration (n=24) | |
Focus (n=6) | |
Motivation (n=5) | |
Emotional impacts
| |
Worry (n=32) | 19. making you worry? |
Depression (n=28) | 21. making you feel depressed? |
Worried about future of PAH (n=18) | |
Upset (n=9) | |
Angry (n=8) | |
Fear (n=8) | |
Feeling low (n=7) | |
Stress (n=6) | |
Frustration (n=5) | |
Physical impact
| |
Climbing stairs (n=37) | 2. making you sit or lie down to rest during the day? |
Walking (n=36) | 3. making it difficult to walk about or climb stairs? |
Exercise/sports (n=34) | 4. making it difficult to work around the house or in the garden? |
Leisure activities (n=33) | 5. making it difficult to go anywhere away from home? |
Carrying things (n=23) | 7. making it difficult to have relationships or do things with your friends or family? |
Lifting (n=17) | 9. making your recreational pastimes, sports or hobbies difficult? |
Bending (n=8) | |
Physical movement (n=6) | |
Pregnancy (n=5) | |
Control of own life (n=26) | 18. making you feel a loss of self-control in your life? |
Impact on relationships
| |
Relationships with friends and family (n=29) | 7. making it difficult to have relationships or do things with your friends or family? |
Sexual activities (n=26) | 10. making your sexual activities difficult? |
Doing things with friends and family (n=21) | 17. making you feel you are a burden to your family or friends? |
Having to rest during the day
| |
Rest during the day (n=35) | 2. making you sit or lie down to rest during the day? |
Rest during activities (n=20) | |
Rest after activities (n=10) | |
Impact on sleep
| |
Problems with sleep (n=22) | 2. making you sit or lie down to rest during the day? |
Problems getting to sleep (n=11) | 6. making it difficult to sleep well at night? |
Quality of sleep (n=9) | |
Problems staying asleep (n=8) | |
Position of sleep (n=5) | |
Social impact
| |
Social isolation (n=11) | 7. making it difficult to have relationships or do things with your friends or family? |
Lack of support and recognition of symptoms by friends and relatives (n=11) | 17. making you feel you are a burden to your family or friends? |
Socializing (n=7) | |
General social impact (n=6) | |
Treatment impact
| 16. giving you side effects from treatments? |
Treatments intrusive and burdensome (n=10) | 15. costing you money for medical care? |
Work impact (n=28) | 8. making it difficult to work to earn a living? |
Positive impacts
| |
Support from friends and family (n=14) | 7. making it difficult to have relationships or do things with your friends or family? |
Impact on eating/diet (n=31) | 11. making you eat less of the things you like? |
Impact on going out
| |
Going out of the house (n=25) | 5. making it difficult to go anywhere away from home? |
Travel (n=18) | |
Preventing from going out (n=10) | |
Going on vacation (n=7) | |
Impact on others
| |
Burden to others (n=20) | 7. making it difficult to have relationships or do things with your friends or family? |
Dependence on others (n=10) | 17. making you feel you are a burden to your family or friends? |
Impact on husband or wife (n=9) | |
Needing support (n=9) | |
Impact on family (n=6) | |
Financial impact
| 15. costing you money for medical care? |
High cost of medication (n=20) |
Psychometric validation study
Variable
[a]
| Baseline LPH population (N=190) |
---|---|
Age
| |
n (missing) | 190 (0) |
Mean (SD) | 48.1 (16.3) |
Median | 48.0 |
Min - Max | 18.0 - 80.0 |
Gender
| |
Male | 44 (23.2%) |
Female | 146 (76.8%) |
Missing | 0 (0.0%) |
WHO functional class
| |
Class I | 7 (3.7%) |
Class II | 79 (41.6%) |
Class III | 101 (53.2%) |
Class IV | 2 (1.1%) |
Missing | 1 (0.5%) |
6 Minute Walking Test at baseline
| |
n (missing) | 188 (2) |
Mean (SD) | 365.0 (67.7) |
Median | 380.0 |
Min - Max | 160.0-468.0 |
Borg Score at baseline
| |
n (missing) | 187 (3) |
Mean (SD) | 3.8 (2.1) |
Median | 3.0 |
Min - Max | 0.0-10.0 |
Quality of completion of the LPH
Scaling properties and confirmation of the structure of the LPH
Dimension | Structural properties of the LPH | Percentages of patients having the lowest or highest possible LPH scores | Internal consistency reliability of LPH scores | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# of items | Range of item-scale correlations | % of items meeting convergent validity criterion
1
| % of items meeting discriminant validity criterion
2
| Lowest possible score | Highest possible score | Baseline LPH population (N=190) | Visit 6/last visit LPH population (N=176) | Baseline | Visit 6/last visit | |||||
N (%) at floor | N (%) at ceiling | N (%) at floor | N (%) at ceiling | N | Cronbach’s Alpha | N | Cronbach’s Alpha | |||||||
LPH Emotional score | 5 | 0.59-0.76 | 100% | 100% | 0 | 25 | 16 (8.42%) | 6 (3.16%) | 16 (9.09%) | 2 (1.14%) | 189 | 0.87 | 176 | 0.87 |
LPH Physical score | 8 | 0.43-0.78 | 100% | 100% | 0 | 40 | 4 (2.11%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 190 | 0.89 | 175 | 0.90 |
LPH Total score | 21 | 0.38-0.72 | 90% | 100% | 0 | 105 | 2 (1.05%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 185 | 0.92 | 171 | 0.92 |
Clinical validity
Concurrent validity
LPH score | LPH score | |||||
---|---|---|---|---|---|---|
LPH emotional score | LPH physical score | LPH total score | LPH emotional score | LPH physical score | LPH total score | |
Correlations with clinical parameters
|
Baseline
|
Week 12
| ||||
Borg score | 0.11 | 0.36 | 0.21 | 0.15 | 0.34 | 0.23 |
Concurrent validity with EQ-5D items
|
Baseline (N=190)
|
Week 12
| ||||
Mobility | 0.26 |
0.51
|
0.41
| 0.12 | 0.37 | 0.27 |
Self-Care | 0.24 | 0.32 | 0.35 | 0.25 |
0.44
|
0.40
|
Usual Activities | 0.36 |
0.46
|
0.45
| 0.30 |
0.48
|
0.41
|
Pain/Discomfort | 0.35 | 0.36 |
0.40
| 0.23 | 0.28 | 0.27 |
Anxiety/Depression |
0.59
|
0.42
|
0.53
|
0.51
| 0.34 |
0.41
|
EQ-5D VAS | 0.26* |
0.48
| 0.35 | -0.20 |
-0.52
| -0.36 |
EQ-5D index |
0.49
|
0.53
|
0.57
|
-0.42
|
-0.52
|
-0.48
|
Responsiveness criteria | Value | LPH emotional score | LPH physical score | LPH total score | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Improved | Stable | Worsened | p-value | Improved | Stable | Worsened | p-value | Improved | Stable | Worsened | p-value | ||
WHO Functional Class | N | 37 | 123 | 10 | p=0.9791 | 38 | 123 | 10 | p=0.0976 | 37 | 123 | 10 | p=0.5096 |
Mean Change | -1.5 | -1.6 | -1.3 | -4.2 | -2.3 | 1.6 | -6.3 | -6.1 | 1.0 | ||||
Effect Size | -0.20 | -0.22 | -0.14 | -0.54 | -0.23 | -0.19 | -0.32 | -0.27 | 0.04 | ||||
Six Minute Walking test | N | 51 | 110 | 10 | p=0.7050 | 51 | 110 | 10 | p=0.1446 | 51 | 110 | 10 | p=0.6578 |
Mean Change | -1.7 | -1.6 | 0.1 | -3.3 | -2.3 | 0.6 | -6.7 | -5.3 | -3.4 | ||||
Effect Size | -0.22 | -0.21 | 0.01 | -0.35 | -0.25 | 0.07 | -0.29 | -0.24 | -0.16 | ||||
Borg score | N | 36 | 121 | 13 | p=0.2237 | 36 | 121 | 13 | p=0.0073 | 36 | 121 | 13 | p=0.0415 |
Mean Change | -1.7 | -1.6 | 0.5 | -5.3 | -1.9 | 0.2 | -9.9 | -4.9 | 0.3 | ||||
Effect Size | -0.26 | -0.21 | 0.06 | -0.61 | -0.20 | 0.02 | -0.46 | -0.23 | 0.01 |
Interpretation of the LPH Scores
LPH scores | N | Standard deviation at baseline | MID using ES=0.2 | MID using ES=0.5 | MID using SEM |
---|---|---|---|---|---|
LPH Emotional score | 190 | 7.38 | 1.48 | 3.69 | 2.66 |
LPH Physical score | 190 | 9.41 | 1.88 | 4.71 | 3.12 |
LPH Total score | 190 | 22.03 | 4.41 | 11.02 | 6.23 |